ID   TALDO_MOUSE             Reviewed;         337 AA.
AC   Q93092; P70358; P70703; Q52KM4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   03-AUG-2022, entry version 181.
DE   RecName: Full=Transaldolase;
DE            EC=2.2.1.2 {ECO:0000269|PubMed:17003133, ECO:0000305|PubMed:27703206};
GN   Name=Taldo1; Synonyms=Tal, Taldo;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9524206; DOI=10.1016/s0378-1119(97)00639-2;
RA   Kusuda J., Hirai M., Toyoda A., Tanuma R., Nomura-Kitabayashi A.,
RA   Hashimoto K.;
RT   "Cloning and chromosomal localization of a paralog and a mouse homolog of
RT   the human transaldolase gene.";
RL   Gene 209:13-21(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N, and FVB/N-3; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 87-97 AND 259-265, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Yang J.W., Zigmond M., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=17003133; DOI=10.1073/pnas.0602678103;
RA   Perl A., Qian Y., Chohan K.R., Shirley C.R., Amidon W., Banerjee S.,
RA   Middleton F.A., Conkrite K.L., Barcza M., Gonchoroff N., Suarez S.S.,
RA   Banki K.;
RT   "Transaldolase is essential for maintenance of the mitochondrial
RT   transmembrane potential and fertility of spermatozoa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14813-14818(2006).
RN   [5]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND PATHWAY.
RX   PubMed=19436114; DOI=10.1172/jci35722;
RA   Hanczko R., Fernandez D.R., Doherty E., Qian Y., Vas G., Niland B.,
RA   Telarico T., Garba A., Banerjee S., Middleton F.A., Barrett D., Barcza M.,
RA   Banki K., Landas S.K., Perl A.;
RT   "Prevention of hepatocarcinogenesis and increased susceptibility to
RT   acetaminophen-induced liver failure in transaldolase-deficient mice by N-
RT   acetylcysteine.";
RL   J. Clin. Invest. 119:1546-1557(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-115 AND LYS-321, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [8]
RP   ALTERNATIVE INITIATION, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF MET-1;
RP   LYS-7; ARG-8; ARG-10 AND MET-11, SUBCELLULAR LOCATION (ISOFORMS 1 AND 2),
RP   INTERACTION WITH KPNA1 AND KPNA4 (ISOFORM 1), AND SUBUNIT.
RX   PubMed=27703206; DOI=10.1038/srep34648;
RA   Moriyama T., Tanaka S., Nakayama Y., Fukumoto M., Tsujimura K., Yamada K.,
RA   Bamba T., Yoneda Y., Fukusaki E., Oka M.;
RT   "Two isoforms of TALDO1 generated by alternative translational initiation
RT   show differential nucleocytoplasmic distribution to regulate the global
RT   metabolic network.";
RL   Sci. Rep. 6:34648-34648(2016).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 13-337.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of mouse transaldolase.";
RL   Submitted (DEC-2005) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the rate-limiting step of the non-oxidative phase
CC       in the pentose phosphate pathway. Catalyzes the reversible conversion
CC       of sedheptulose-7-phosphate and D-glyceraldehyde 3-phosphate into
CC       erythrose-4-phosphate and beta-D-fructose 6-phosphate (PubMed:17003133,
CC       PubMed:27703206). Not only acts as a pentose phosphate pathway enzyme,
CC       but also affects other metabolite pathways by altering its subcellular
CC       localization between the nucleus and the cytoplasm (PubMed:27703206).
CC       {ECO:0000269|PubMed:17003133, ECO:0000269|PubMed:27703206}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glyceraldehyde 3-phosphate + D-sedoheptulose 7-phosphate =
CC         beta-D-fructose 6-phosphate + D-erythrose 4-phosphate;
CC         Xref=Rhea:RHEA:17053, ChEBI:CHEBI:16897, ChEBI:CHEBI:57483,
CC         ChEBI:CHEBI:57634, ChEBI:CHEBI:59776; EC=2.2.1.2;
CC         Evidence={ECO:0000269|PubMed:17003133, ECO:0000305|PubMed:27703206};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17054;
CC         Evidence={ECO:0000305|PubMed:27703206};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17055;
CC         Evidence={ECO:0000305|PubMed:27703206};
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       glyceraldehyde 3-phosphate and beta-D-fructose 6-phosphate from D-
CC       ribose 5-phosphate and D-xylulose 5-phosphate (non-oxidative stage):
CC       step 2/3. {ECO:0000269|PubMed:19436114}.
CC   -!- SUBUNIT: Homodimer (PubMed:27703206). Heterodimer with isoform 2
CC       (PubMed:27703206). Interacts with KPNA1 and KPNA4 (PubMed:27703206).
CC       {ECO:0000269|PubMed:27703206}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:27703206}. Cytoplasm {ECO:0000269|PubMed:27703206}.
CC       Note=Shuttles between the nucleus and the cytoplasm. Actively
CC       transported into the nucleus in an importin alpha/beta-dependent manner
CC       (PubMed:27703206). Exported into the cytoplasm by CRM1
CC       (PubMed:27703206). {ECO:0000269|PubMed:27703206}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:27703206}. Note=Imported into the nucleus when
CC       incorporated in isoform 1/isoform 2 homodimer.
CC       {ECO:0000269|PubMed:27703206}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1; Synonyms=TALDO1L {ECO:0000303|PubMed:27703206};
CC         IsoId=Q93092-1; Sequence=Displayed;
CC       Name=2; Synonyms=TALDO1S {ECO:0000303|PubMed:27703206};
CC         IsoId=Q93092-2; Sequence=VSP_061596;
CC   -!- DOMAIN: The first 10 amino acids are essential for nuclear
CC       localization. {ECO:0000269|PubMed:27703206}.
CC   -!- DISRUPTION PHENOTYPE: Deficient mice develop normally; however, males
CC       are sterile because of functional and structural defects of
CC       mitochondria (PubMed:17003133). Mice spontaneously develop
CC       hepatocellular carcinoma. The liver of these mice present an
CC       accumulation of five-carbon sugarphosphates and a depletion of NADPH
CC       and GSH (PubMed:19436114). {ECO:0000269|PubMed:17003133,
CC       ECO:0000269|PubMed:19436114}.
CC   -!- SIMILARITY: Belongs to the transaldolase family. Type 1 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB08722.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U67611; AAB83955.1; -; mRNA.
DR   EMBL; U63158; AAB08722.1; ALT_INIT; mRNA.
DR   EMBL; U63159; AAB08723.1; -; mRNA.
DR   EMBL; BC004754; AAH04754.1; -; mRNA.
DR   EMBL; BC094277; AAH94277.1; -; mRNA.
DR   CCDS; CCDS22011.1; -.
DR   RefSeq; NP_035658.1; NM_011528.4.
DR   PDB; 2CWN; X-ray; 2.10 A; A/B=13-337.
DR   PDB; 2E1D; X-ray; 2.00 A; A/B=11-334.
DR   PDBsum; 2CWN; -.
DR   PDBsum; 2E1D; -.
DR   AlphaFoldDB; Q93092; -.
DR   SMR; Q93092; -.
DR   BioGRID; 203964; 12.
DR   IntAct; Q93092; 1.
DR   STRING; 10090.ENSMUSP00000026576; -.
DR   iPTMnet; Q93092; -.
DR   PhosphoSitePlus; Q93092; -.
DR   SwissPalm; Q93092; -.
DR   REPRODUCTION-2DPAGE; IPI00124692; -.
DR   REPRODUCTION-2DPAGE; Q93092; -.
DR   CPTAC; non-CPTAC-3950; -.
DR   EPD; Q93092; -.
DR   jPOST; Q93092; -.
DR   MaxQB; Q93092; -.
DR   PaxDb; Q93092; -.
DR   PeptideAtlas; Q93092; -.
DR   PRIDE; Q93092; -.
DR   ProteomicsDB; 263001; -.
DR   Antibodypedia; 22640; 278 antibodies from 32 providers.
DR   Ensembl; ENSMUST00000026576; ENSMUSP00000026576; ENSMUSG00000025503.
DR   GeneID; 21351; -.
DR   KEGG; mmu:21351; -.
DR   UCSC; uc009kkv.2; mouse.
DR   CTD; 6888; -.
DR   MGI; MGI:1274789; Taldo1.
DR   VEuPathDB; HostDB:ENSMUSG00000025503; -.
DR   eggNOG; KOG2772; Eukaryota.
DR   GeneTree; ENSGT00390000017361; -.
DR   HOGENOM; CLU_047470_0_1_1; -.
DR   InParanoid; Q93092; -.
DR   OMA; KFGYKTL; -.
DR   OrthoDB; 1402459at2759; -.
DR   PhylomeDB; Q93092; -.
DR   TreeFam; TF300757; -.
DR   Reactome; R-MMU-163754; Insulin effects increased synthesis of Xylulose-5-Phosphate.
DR   Reactome; R-MMU-71336; Pentose phosphate pathway.
DR   UniPathway; UPA00115; UER00414.
DR   BioGRID-ORCS; 21351; 1 hit in 70 CRISPR screens.
DR   ChiTaRS; Taldo1; mouse.
DR   EvolutionaryTrace; Q93092; -.
DR   PRO; PR:Q93092; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q93092; protein.
DR   Bgee; ENSMUSG00000025503; Expressed in granulocyte and 265 other tissues.
DR   ExpressionAtlas; Q93092; baseline and differential.
DR   Genevisible; Q93092; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0048029; F:monosaccharide binding; ISO:MGI.
DR   GO; GO:0004801; F:transaldolase activity; IDA:MGI.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0006002; P:fructose 6-phosphate metabolic process; ISO:MGI.
DR   GO; GO:0019682; P:glyceraldehyde-3-phosphate metabolic process; ISO:MGI.
DR   GO; GO:0006098; P:pentose-phosphate shunt; IDA:MGI.
DR   GO; GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; ISO:MGI.
DR   CDD; cd00957; Transaldolase_TalAB; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00492; Transaldolase_1; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR001585; TAL/FSA.
DR   InterPro; IPR004730; Transaldolase_1.
DR   InterPro; IPR018225; Transaldolase_AS.
DR   PANTHER; PTHR10683; PTHR10683; 1.
DR   PANTHER; PTHR10683:SF18; PTHR10683:SF18; 1.
DR   Pfam; PF00923; TAL_FSA; 1.
DR   TIGRFAMs; TIGR00874; talAB; 1.
DR   PROSITE; PS01054; TRANSALDOLASE_1; 1.
DR   PROSITE; PS00958; TRANSALDOLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Cytoplasm;
KW   Direct protein sequencing; Nucleus; Pentose shunt; Phosphoprotein;
KW   Reference proteome; Schiff base; Transferase.
FT   CHAIN           1..337
FT                   /note="Transaldolase"
FT                   /id="PRO_0000173565"
FT   MOTIF           1..10
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   ACT_SITE        142
FT                   /note="Schiff-base intermediate with substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P37837"
FT   MOD_RES         115
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         219
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P37837"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         256
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P37837"
FT   MOD_RES         269
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P37837"
FT   MOD_RES         286
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P37837"
FT   MOD_RES         321
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   VAR_SEQ         1..10
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_061596"
FT   MUTAGEN         1
FT                   /note="M->A: Leads to expression of isoform 2 only."
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   MUTAGEN         7
FT                   /note="K->A: Mainly expressed in the cytoplasm; when
FT                   associated with A-8 and A-10."
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   MUTAGEN         8
FT                   /note="R->A: Mainly expressed in the cytoplasm; when
FT                   associated with A-7 and A-10."
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   MUTAGEN         10
FT                   /note="R->A: Mainly expressed in the cytoplasm; when
FT                   associated with A-7 and A-8."
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   MUTAGEN         11
FT                   /note="M->A: Leads to expression of isoform 1 only."
FT                   /evidence="ECO:0000269|PubMed:27703206"
FT   CONFLICT        207..213
FT                   /note="EPQEDPG -> DPRKTW (in Ref. 1; AAB08723)"
FT                   /evidence="ECO:0000305"
FT   HELIX           14..18
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   TURN            19..21
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          22..27
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           31..33
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   TURN            34..37
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           46..53
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           56..58
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           59..72
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           76..98
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          103..106
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           115..131
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          139..144
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           147..160
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          164..169
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           172..181
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          184..190
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           191..200
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           212..226
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          232..236
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           241..245
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   TURN            246..249
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           257..265
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           276..279
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           291..299
FT                   /evidence="ECO:0007829|PDB:2E1D"
FT   HELIX           302..330
FT                   /evidence="ECO:0007829|PDB:2E1D"
SQ   SEQUENCE   337 AA;  37387 MW;  B0AD351FD778367F CRC64;
     MSGSPVKRQR MESALDQLKQ FTTVVADTGD FNAIDEYKPQ DATTNPSLIL AAAQMPAYQE
     LVEEAIAYGK KLGGPQEEQI KNAIDKLFVL FGAEILKKIP GRVSTEVDAR LSFDKDAMVA
     RARRLIELYK EAGVGKDRIL IKLSSTWEGI QAGKELEEQH GIHCNMTLLF SFAQAVACAE
     AGVTLISPFV GRILDWHVAN TDKKSYEPQE DPGVKSVTKI YNYYKKFGYK TIVMGASFRN
     TGEIKALAGC DFLTISPKLL GELLKDNSKL APALSVKAAQ TSDSEKIHLD EKAFRWLHNE
     DQMAVEKLSD GIRKFAADAI KLERMLTERM FSAENGK
//
